What does CUSIP 29251M106 represent in this 13F holders report?

CUSIP 29251M106 is the security identifier for ENTA - ENANTA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in Q2 2015?

129 institutional investors reported ENTA - ENANTA PHARMACEUTICALS INC - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 28,862,345
Total 13F shares: 13,813,121
Share change: +1,464,264
Total reported value: $620,989,034
Put/Call ratio: 83%
Price per share: $44.99
Number of holders: 129
Value change: +$81,244,568
Number of buys: 86
Number of sells: 45

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 29251M106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Consonance Capital Management LP	13F	Company	5.4%	1,552,962	$47,552,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	4.7%	1,359,435	$41,626,000	—	31 Mar 2015	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	3.9%	1,127,238	$34,516,000	—	31 Mar 2015	13F
Apex Capital Management	13F	Company	3.8%	1,103,123	$33,778,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	2.7%	778,528	$23,836,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	2%	578,877	$17,725,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	1.8%	526,625	$16,125,000	—	31 Mar 2015	13F
McClain Value Management LLC	13F	Company	1.5%	444,328	$13,605,000	—	31 Mar 2015	13F
Krensavage Asset Management, LLC	13F	Company	1.5%	424,016	$12,983,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.1%	324,645	$9,941,000	—	31 Mar 2015	13F
MANAGED ACCOUNT ADVISORS LLC	13F	Company	1.1%	314,511	$9,630,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	0.99%	284,476	$8,711,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.92%	266,927	$8,173,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.56%	162,390	$4,973,000	—	31 Mar 2015	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	0.53%	154,300	$4,725,000	—	31 Mar 2015	13F
WALL STREET ASSOCIATES	13F	Company	0.53%	151,800	$4,648,000	—	31 Mar 2015	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.51%	148,610	$4,550,000	—	31 Mar 2015	13F
Endurant Capital Management LP	13F	Company	0.45%	131,100	$4,014,000	—	31 Mar 2015	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.4%	116,700	$3,996,000	—	31 Mar 2015	13F
APIS CAPITAL ADVISORS, LLC	13F	Company	0.51%	146,955	$3,847,000	—	31 Mar 2015	13F
MARSHALL WACE, LLP	13F	Company	0.43%	123,457	$3,780,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.42%	120,676	$3,696,000	—	31 Mar 2015	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.36%	105,014	$3,216,000	—	31 Mar 2015	13F
BAILARD, INC.	13F	Company	0.35%	100,000	$3,062,000	—	31 Mar 2015	13F
GREAT POINT PARTNERS LLC	13F	Company	0.35%	100,000	$3,062,000	—	31 Mar 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.31%	89,103	$2,728,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	85,331	$2,612,000	—	31 Mar 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.29%	85,104	$2,606,000	—	31 Mar 2015	13F
QS Investors, LLC	13F	Company	0.27%	77,513	$2,373,000	—	31 Mar 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	0.26%	75,357	$2,307,000	—	31 Mar 2015	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.26%	74,696	$2,288,000	—	31 Mar 2015	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.21%	61,709	$1,890,000	—	31 Mar 2015	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.2%	58,091	$1,779,000	—	31 Mar 2015	13F
BlackRock Japan Co. Ltd	13F	Company	0.18%	50,833	$1,557,000	—	31 Mar 2015	13F
Gotham Asset Management, LLC	13F	Company	0.17%	47,871	$1,466,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.16%	45,508	$1,393,000	—	31 Mar 2015	13F
GUGGENHEIM CAPITAL LLC	13F	Company	0.16%	45,195	$1,384,000	—	31 Mar 2015	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.15%	44,497	$1,363,000	—	31 Mar 2015	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.14%	41,462	$1,270,000	—	31 Mar 2015	13F
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO	13F	Company	0.13%	38,400	$1,176,000	—	31 Mar 2015	13F
Municipal Employees' Retirement System of Michigan	13F	Company	0.12%	34,550	$1,058,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.12%	34,223	$1,048,000	—	31 Mar 2015	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.12%	33,973	$1,040,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.11%	30,364	$929,000	—	31 Mar 2015	13F
AXA S.A.	13F	Company	0.11%	30,350	$929,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.11%	30,342	$929,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.1%	29,918	$916,000	—	31 Mar 2015	13F
Airain ltd	13F	Company	0.1%	29,546	$905,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	28,639	$877,000	—	31 Mar 2015	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.09%	25,393	$777,000	—	31 Mar 2015	13F

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q2 2015

As of 30 Jun 2015, ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,813,121 shares. The largest 10 holders included EAGLE ASSET MANAGEMENT INC, Consonance Capital Management LP, Apex Capital Management, FMR LLC, STATE STREET CORP, Krensavage Asset Management, LLC, BlackRock Fund Advisors, Invesco Ltd., MCCLAIN VALUE MANAGEMENT LLC, and Voya Investment Management LLC. This page lists 129 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

115

Q2 2015 holders

129

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.